CAMBRIDGE, Mass.–(BUSINESS WIRE)–Oct. 15, 2018– Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that in consultation
Continue reading »Home ยป
mypharmacynews.com
Home ยป
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Oct. 15, 2018– Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that in consultation
Continue reading »